A Case Series of Patients with Severe Pulmonary Hypertension Receiving an Implantable Pump for Intravenous Prostanoid Therapy

Dosing considerations in the use of intravenous prostanoids in pulmonary arterial hypertension: An experience-based review

(2009) Ronald J. Oudiz et al.   AMERICAN HEART JOURNAL

Long-term outcome with intravenous iloprost in pulmonary arterial hypertension

(2009) M. M. Hoeper et al.   EUROPEAN RESPIRATORY JOURNAL

Closed-Hub Systems with Protected Connections and the Reduction of Risk of Catheter-Related Bloodstream Infection in Pediatric Patients Receiving Intravenous Prostanoid Therapy for Pulmonary Hypertension

(2009) D. Dunbar Ivy et al.   INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY

Low Complication Rates With Totally Implantable Access Port Use in Epoprostenol Treatment of Pulmonary Hypertension

(2009) Michael G. Dickinson et al.   JOURNAL OF HEART AND LUNG TRANSPLANTATION

Exercise improvement and plasma biomarker changes with intravenous treprostinil therapy for pulmonary arterial hypertension: A placebo-controlled trial

(2009) Jagdish Hiremath et al.   JOURNAL OF HEART AND LUNG TRANSPLANTATION

Guidelines for the prevention of central venous catheter-related blood stream infections with prostanoid therapy for pulmonary arterial hypertension

(2008) A. K. Doran et al.   INTERNATIONAL JOURNAL OF CLINICAL PRACTICE

Dose Proportionality of Treprostinil Sodium Administered by Continuous Subcutaneous and Intravenous Infusion

(2007) C. Shane McSwain et al.   JOURNAL OF CLINICAL PHARMACOLOGY